» Articles » PMID: 18458172

Asymptomatic Peripheral Arterial Disease is Associated with More Adverse Lower Extremity Characteristics Than Intermittent Claudication

Abstract

Background: This study assessed functional performance, calf muscle characteristics, peripheral nerve function, and quality of life in asymptomatic persons with peripheral arterial disease (PAD).

Methods And Results: PAD participants (n=465) had an ankle brachial index <0.90. Non-PAD participants (n=292) had an ankle brachial index of 0.90 to 1.30. PAD participants were categorized into leg symptom groups including intermittent claudication (n=215) and always asymptomatic (participants who never experienced exertional leg pain, even during the 6-minute walk; n=72). Calf muscle was measured with computed tomography. Analyses were adjusted for age, sex, race, ankle brachial index, comorbidities, and other confounders. Compared with participants with intermittent claudication, always asymptomatic PAD participants had smaller calf muscle area (4935 versus 5592 mm(2); P<0.001), higher calf muscle percent fat (16.10% versus 9.45%; P<0.001), poorer 6-minute walk performance (966 versus 1129 ft; P=0.0002), slower usual-paced walking speed (P=0.0019), slower fast-paced walking speed (P<0.001), and a poorer Short-Form 36 Physical Functioning score (P=0.016). Compared with an age-matched, sedentary, non-PAD cohort, always asymptomatic PAD participants had smaller calf muscle area (5061 versus 5895 mm(2); P=0.009), poorer 6-minute walk performance (1126 versus 1452 ft; P<0.001), and poorer Walking Impairment Questionnaire speed scores (40.87 versus 57.78; P=0.001).

Conclusions: Persons with PAD who never experience exertional leg symptoms have poorer functional performance, poorer quality of life, and more adverse calf muscle characteristics compared with persons with intermittent claudication and a sedentary, asymptomatic, age-matched group of non-PAD persons.

Citing Articles

Neuromuscular Junction Damage in the Calf Muscles of Patients With Advanced Peripheral Artery Disease.

Tu H, Hakim A, Kim J, Zhu Z, Tian Y, Pipinos I Neuropathol Appl Neurobiol. 2025; 51(1):e70008.

PMID: 39989162 PMC: 11848508. DOI: 10.1111/nan.70008.


Single-centre, double-blinded, randomised placebo-controlled trial to determine the effect of a 12-week home-based programme of footplate neuromuscular electrical stimulation on walking capacity in people with peripheral artery disease: a protocol....

Askew C, Windsor M, Feka K, Russell F, Schaumberg M, Walker M BMJ Open. 2025; 15(1):e093162.

PMID: 39863411 PMC: 11784211. DOI: 10.1136/bmjopen-2024-093162.


Peripheral artery disease and outcomes: how can we improve risk prediction?.

Yanamandala M, Goudot G, Gerhard-Herman M Eur Heart J. 2024; 45(19):1750-1752.

PMID: 38607986 PMC: 11107121. DOI: 10.1093/eurheartj/ehae154.


Design and use of an ex vivo peripheral simulating bioreactor system for pharmacokinetic analysis of a drug coated stent.

Chen D, Krinsky C, Phillips M, Allred C, Khan A, Liu L Bioeng Transl Med. 2024; 9(2):e10618.

PMID: 38435812 PMC: 10905536. DOI: 10.1002/btm2.10618.


Ankle Brachial Index: An Easy and First-Choice Screening Marker of Peripheral Artery Disease and Physical Function.

Horie K J Atheroscler Thromb. 2024; 31(4):353-354.

PMID: 38233205 PMC: 10999712. DOI: 10.5551/jat.ED252.


References
1.
McDermott M, Fried L, Simonsick E, Ling S, Guralnik J . Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation. 2000; 101(9):1007-12. DOI: 10.1161/01.cir.101.9.1007. View

2.
McDermott M, Kerwin D, Liu K, Martin G, OBrien E, Kaplan H . Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. J Gen Intern Med. 2001; 16(6):384-90. PMC: 1495229. DOI: 10.1046/j.1525-1497.2001.016006384.x. View

3.
Shadman R, Criqui M, Bundens W, Fronek A, Denenberg J, Gamst A . Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol. 2004; 44(3):618-23. DOI: 10.1016/j.jacc.2004.04.044. View

4.
Mitsiopoulos N, Baumgartner R, Heymsfield S, Lyons W, Gallagher D, Ross R . Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998; 85(1):115-22. DOI: 10.1152/jappl.1998.85.1.115. View

5.
Garg P, Tian L, Criqui M, Liu K, Ferrucci L, Guralnik J . Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation. 2006; 114(3):242-8. PMC: 2645622. DOI: 10.1161/CIRCULATIONAHA.105.605246. View